• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » benzodiazepines

Articles Tagged with ''benzodiazepines''

Research Update

Benzodiazepines, Quetiapine, and Pregabalin for Short-Term Anxiety

February 1, 2025
Dominic Le, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Dominic Le, MD. Dr. Le has no financial relationships with companies related to this material.

Does medication work for rapid reduction of anxiety? This review finds some surprising answers. 


Read More
Fact Sheet

How to Choose a Benzodiazepine for Alcohol Withdrawal

January 1, 2025
Daniel Carlat, MD, Michael Weaver, MD, FASAM, and Talia Puzantian, PharmD, BCPP

Dr. Carlat, Dr. Weaver, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

  • There are many benzodiazepines to choose from.



  • Read More
    Clinical Guidance

    How to Manage Anxiety with Non-Addictive Medications

    November 19, 2024
    Victoria Hendrick, MD and Daniel Carlat, MD

    Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Many patients with substance use disorders experience significant anxiety and agitation.




    Read More
    CarlatPsychEp1.png
    CARLAT WEBINAR

    Carlat Psychiatry News - Stimulant Fraud • Oral Ketamine • E-Cigarettes • Benzo Tapering • CBD

    September 17, 2024
    Chris Aiken, MD, Greg Malzberg, MD, and Kellie Newsome, PMHNP

    0.25 CME Credits. In this episode, we explore nine groundbreaking stories in mental health and psychiatric medicine, covering everything from healthcare fraud to the latest advancements in drug trials. First, we dive into the recent charges brought by the US Department of Justice against executives at Done, a California-based telehealth company, for alleged healthcare fraud. Done is accused of prescribing over 40 million Adderall pills to patients without proper evaluation, raising concerns about the balance between increasing mental healthcare access and responsible prescribing practices.


    Read More
    shutterstock_2495815855.jpg

    Six Research Updates

    August 5, 2024
    Chris Aiken, MD and Kellie Newsome, PMHNP

    Research updates on benzo discontinuation, iloperidone in mania, lithium, schizophrenia, ECT, a new circadian psychotherapy, and therapy for multi-trauma PTSD.



    Read More
    shutterstock_2425592969.jpg

    Throwback Benzos

    February 15, 2024
    Chris Aiken, MD and Kellie Newsome, PMHNP

    The release of the fast-acting antidepressant Auvelity got us thinking about an older strategy to speed up antidepressants: benzodiazepines. So we're bringing you this Thursday throwback, do benzodiazepines treat depression? Benzos and sleep meds rarely earn a mention in textbooks on depression these days, but that has not always been the case. (Part 1 of a 2 part series)


    Read More
    Clinical Update

    Inpatient Use of Benzodiazepines for Patients With Substance Use Disorders

    January 31, 2024
    Audrey Abelleira, PharmD, BCPP
    From The Carlat Hospital Psychiatry Report
    Issue Links: Editorial Information | PDF of Issue

    Audrey Abelleira, PharmD, BCPP. Clinical pharmacist practitioner, VA Connecticut Healthcare System; clinical instructor, Yale School of Medicine, New Haven, CT.

    Dr. Abelleira has no financial relationships with companies related to this material.

    Benzodiazepines are highly beneficial for managing anxiety and agitation in psychiatric inpatient settings, but we must be cautious about prescribing them to patients with substance use disorders (SUDs). Here we review strategies to reduce the risk of benzodiazepine misuse and discuss alternative medication options, including second-generation antipsychotics, antidepressants, gabapentin, and pregabalin.


    Read More
    Expert Q&A

    Alcohol Withdrawal: What to Watch For on the Psychiatric Inpatient Unit

    January 31, 2024
    Caridad Ponce Martinez, MD, FAPA, FASAM
    From The Carlat Hospital Psychiatry Report
    Issue Links: Editorial Information | PDF of Issue

    QA2_Caridad Ponce Martinez_photo.jpgCaridad Ponce Martinez, MD, FAPA, FASAM.

    Assistant professor of psychiatry, UMass Chan Medical School, Worcester, MA.

    Dr. Ponce Martinez has no financial relationships with companies related to this material.

    Dr. Ponce Martinez highlights the need to identify and manage alcohol withdrawal in psychiatric settings, underscoring the use of the CIWA-Ar scale for monitoring symptom progression. While benzodiazepines remain the primary treatment, she reviews alternative treatment strategies and tells us which patients are so high risk that they must be transferred to a medical unit for care.


    Read More
    Expert Q&A

    When and How Should We Prescribe Benzos?

    October 31, 2023
    Tae Woo (Ted) Park, MD
    From The Carlat Addiction Treatment Report
    Issue Links: Editorial Information | PDF of Issue

    QA_Benzo-Prescribing_TaeWooPark.JPGTae Woo (Ted) Park, MD. Assistant professor, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA.

    Dr. Park has no financial relationships with companies related to this material. 

    Despite their risks, benzodiazepines remain a widely prescribed class of medication. In the prescriber right hands, benzodiazepines can help many patients cope with a variety of psychiatric issues. Here, Dr. Park reviews how to evaluate patients prior to starting benzodiazepines and reviews strategies to ensure that prescriptions are done safely.


    Read More
    Expert Q&A

    Deprescribing Benzos: A How-To Guide

    October 31, 2023
    Audrey Abelleira, PharmD, BCPP
    From The Carlat Addiction Treatment Report
    Issue Links: Editorial Information | PDF of Issue

    QA_Addiction--Prescriptions_Abelleira.jpgAudrey Abelleira, PharmD, BCPP. Clinical pharmacist practitioner, VA Connecticut Healthcare System; clinical instructor, Yale School of Medicine, New Haven, CT.

    Dr. Abelleira has no financial relationships with companies related to this material.


    Benzodiazepines are widely prescribed but carry significant risks. The best course of action for many patients is to have their benzodiazepine prescription discontinued, but physiologic dependence can make stopping benzodiazepines a big challenge. Dr. Abeillera teaches us how to identify those who might benefit from a taper and covers all the details on how to do it as safely and effectively as possible. 


    Read More
    Previous 1 2 3 4 5 6 7 Next
    Try The New AskCarlat AI

    Ask any clinical question—our AI responds using only the peer-reviewed, editorially vetted content from Carlat Publishing.

    Available In The Carlat Toolkit
    Free Psychiatry Updates
    The latest unbiased psychiatric information sent to your inbox.
    Specify Your Interests
    Featured Book
    • MFB8e_SpiralCover.png

      Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

      Updated 2026 prescriber's guide.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2772531237.jpg
      General Psychiatry

      Gender Affirming Care in Exile: The Lawsuits

      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.